Meropenem 1GM+Sulbactum 500MG Injection

Meropenem 1g + Sulbactam 500mg Injection
Enhanced Spectrum. Elevated Protection Against Resistance.

Meropenem + Sulbactam Injection combines the powerful carbapenem antibiotic Meropenem with the β-lactamase inhibitor Sulbactam, delivering a synergistic effect against a broad range of multidrug-resistant (MDR) bacterial pathogens. This combination is especially effective in managing complicated and hospital-acquired infections where resistance is a major concern.

Key Benefits:

• Potent Broad-Spectrum Coverage:
  Effective against Gram-positive, Gram-negative, anaerobic, and β-lactamase-producing organisms, including resistant strains.

• Enhanced Activity Against MDR Pathogens:
  Sulbactam inhibits β-lactamase enzymes, protecting Meropenem from enzymatic degradation and expanding its efficacy.

• Ideal for Critical Infections:
  Suitable for treating severe infections in ICU, post-surgical, and immunocompromised patients.

• Reliable Tissue Penetration:
  Ensures therapeutic levels in lungs, CSF, urinary tract, and intra-abdominal regions.

Indications:
Indicated for the treatment of serious and resistant infections such as:

• Complicated intra-abdominal infections

• Hospital-acquired and ventilator-associated pneumonia

• Complicated urinary tract infections

• Skin and soft tissue infections

• Septicemia and bacteremia

• Infections caused by ESBL-producing and other resistant organisms

Dosage & Administration:
Administered via intravenous infusion. Dose and duration as prescribed by the physician, based on infection severity and renal function.

Important Safety Information:
Use with caution in patients with a history of hypersensitivity to β-lactam antibiotics. Monitor renal function during prolonged therapy. Common side effects may include rash, diarrhea, nausea, and infusion site reactions.